Your browser doesn't support javascript.
loading
High-Risk Patients with Infected Puncture Wounds and Appropriate Tetanus Prophylaxis.
Truong, David H; Malone, Matthew; Fontaine, Javier La; Wukich, Dane K; Oz, Orhan K; Lavery, Lawrence A.
Afiliación
  • Truong DH; *Surgical Service, Podiatry Section, Veterans Affairs North Texas Health Care System, Dallas, TX.
  • Malone M; †Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX.
  • Fontaine J; ‡South West Sydney Limb Preservation and Wound Research Academic Unit, Liverpool Hospital, South West Sydney Local Health District, Sydney, Australia.
  • Wukich DK; §Infectious Diseases and Microbiology, School of Medicine, Western Sydney University, Campbelltown Campus, Sydney, Australia.
  • Oz OK; †Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX.
  • Lavery LA; ‖Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, TX.
J Am Podiatr Med Assoc ; 113(1)2023.
Article en En | MEDLINE | ID: mdl-34233358
BACKGROUND: We sought to evaluate clinicians' compliance with national guidelines for tetanus vaccination prophylaxis in patients with high-risk feet. METHODS: We retrospectively evaluated 114 consecutive patients between June 1, 2011, and March 31, 2019, who presented to the emergency department with a foot infection resulting from a puncture injury. Eighty-three patients had diabetes mellitus and 31 patients did not have diabetes mellitus. Electronic medical records were used to collect a broad range of study data on patient demographics, medical history, tetanus immunization history and tetanus status on presentation to the emergency department, peripheral arterial disease, sensory neuropathy, laboratory values, and clinical/surgical outcomes. RESULTS: Of the 114 patients who presented to the emergency department with a puncture wound, 53 (46.5%) did not have up-to-date tetanus immunization. Of those patients, 79.2% received a tetanus-containing vaccine booster, 3.8% received intramuscular tetanus immunoglobulin, 3.8% received both a tetanus-containing vaccine booster and tetanus immunoglobulins, and 20.8% received no form of tetanus prophylaxis. Comparing data between patients with and without diabetes mellitus, there were no statistically significant differences in tetanus prophylaxis. CONCLUSIONS: Guidelines for tetanus prophylaxis among high-risk podiatric medical patients in this study center are not followed in all patients. Patients with diabetes mellitus are at high risk for exposure to tetanus; therefore, we recommend that physicians take a detailed tetanus immunization history and vaccinate patients if the tetanus history is unclear.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tétanos / Infección de Heridas / Heridas y Lesiones / Diabetes Mellitus Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: J Am Podiatr Med Assoc Asunto de la revista: PODIATRIA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tétanos / Infección de Heridas / Heridas y Lesiones / Diabetes Mellitus Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: J Am Podiatr Med Assoc Asunto de la revista: PODIATRIA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos